Valuation: Astec LifeSciences Limited

Market Cap 15.83B 167M 148M 137M 125M 236M 240M 1.65B 648M 8.26B 626M 613M 26.34B P/E 2027 *
-56.8x
P/E 2028 * 64.6x
Enterprise Value 15.83B 167M 148M 137M 125M 236M 240M 1.65B 648M 8.26B 626M 613M 26.34B EV / Sales 2027 *
2.83x
EV / Sales 2028 * 2.14x
Free-Float
26.92%
Yield 2027 *
0.21%
Yield 2028 * 0.18%
1 day-2.21%
1 week-2.58%
Current month-1.70%
1 month+7.33%
3 months+1.43%
6 months-5.30%
Current year+0.77%
1 week 705.2
Extreme 705.2
739.85
1 month 684.8
Extreme 684.8
825.95
Current year 513.4
Extreme 513.4
850
1 year 513.4
Extreme 513.4
941.75
3 years 513.4
Extreme 513.4
1,474.4
5 years 513.4
Extreme 513.4
2,288.8
10 years 305
Extreme 305
2,288.8
Manager TitleAgeSince
Director of Finance/CFO - 31/03/2026
Compliance Officer - 31/10/2018
Chief Operating Officer 56 30/11/2015
Director TitleAgeSince
Chairman 71 24/01/1994
Director/Board Member 56 12/04/2026
Director/Board Member 71 29/01/2020
Date Insider Type Main position Quantity % Market Cap. Importance
02/01/25 Buy 134,873 0.6877%
02/01/25 Buy

Chairman

404,782 2.0640%
02/01/25 Buy 134,954 0.6881%
Change 5-day change 1-year change 3-year change Capi.($)
-2.21%-2.58%-2.40%-46.17% 167M
+2.07%+4.65%+27.17%+20.69% 34.01B
+0.48%-4.28%+3.22%+35.17% 18.24B
+0.90%+8.35%+45.57%+43.32% 18.29B
-1.68%-4.54%-9.80%-17.97% 14.13B
+0.11%-.--%-.--%-.--% 12.96B
-0.17%-0.36%+7.71%+4.46% 11.12B
-0.40%-3.64%+12.14%+174.85% 10.47B
0.00%-2.72% - - 8.59B
-0.22%-.--%-.--%-.--% 8.3B
Average +0.00%-0.02%+9.29%+23.82% 13.63B
Weighted average by Cap. +0.55%+1.18%+14.81%+29.41%

Financials

2027 *2028 *
Net sales 5.6B 58.95M 52.4M 48.57M 44.19M 83.39M 84.73M 584M 229M 2.92B 221M 217M 9.31B 7.41B 78.07M 69.39M 64.32M 58.52M 110M 112M 773M 303M 3.87B 293M 287M 12.33B
Net income -279M -2.94M -2.61M -2.42M -2.2M -4.16M -4.22M -29.11M -11.41M -146M -11.03M -10.8M -464M 246M 2.59M 2.3M 2.14M 1.94M 3.67M 3.73M 25.67M 10.06M 128M 9.73M 9.52M 409M
Net Debt - -
Projected Income Statement - Annual - Astec LifeSciences Limited
Logo Astec LifeSciences Limited
Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range of agrochemicals. The Company operates through a single segment, namely Agrochemicals. Its product categories include Fungicide, Growth Regulator, Intermediates, Insecticide, and Herbicide. Its products include Azimsulfuron, Halosulfuron, Flutriafol, Rimsulfuron, Transfluthrin, Prothiaconazole, Metalaxyl, Cyproconazole, and Tribenuron methyl. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries, including the United States and countries across Europe, West Asia, South-East Asia, Latin America and Africa. The Company has approximately nine manufacturing plants, which are located in Maharashtra.
Employees
471
Date Price Change Volume
16/10/26 ₹710.45 -2.21% 20,703
15/10/26 ₹726.50 +0.71% 19,416
14/10/26 ₹721.35 -0.56% 15,577
13/10/26 ₹725.40 -0.75% 38,847
12/10/26 ₹730.85 +0.21% 22,977
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Astec LifeSciences Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
710.45INR
Average target price
670.00INR
Spread / Average Target
-5.69%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Astec LifeSciences Limited
  1. Stock Market
  2. Stocks
  3. ASTEC Stock